Shenzhen Neptunus Bioengineering Co., Ltd.

SZSE:000078.SZ

2.96 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue 36,418.7737,834.85941,053.58440,022.49541,492.70438,380.90724,939.63813,605.92211,117.7359,802.3517,993.4346,418.0225,305.0293,999.0522,710.0432,211.82,495.0022,690.7852,657.9922,321.9471,281.648829.428765.052198.97788.39264.47762.67377.82949.825
Cost of Revenue 32,865.44534,045.03536,655.49435,375.25635,971.88533,340.11621,344.13911,582.2679,489.4928,371.7316,782.9425,447.9654,424.1883,342.062,243.7311,861.6522,143.4352,329.1812,410.8281,846.149924.255231.301235.00741.86719.96316.4315.54519.6420.6
Gross Profit 3,553.3253,789.8244,398.094,647.245,520.8195,040.7913,595.4992,023.6551,628.2431,430.621,210.492970.057880.841656.993466.312350.148351.567361.604247.164475.798357.392598.127530.045157.1168.42948.04747.12958.18929.224
Gross Profit Ratio 0.0980.10.1070.1160.1330.1310.1440.1490.1460.1460.1510.1510.1660.1640.1720.1580.1410.1340.0930.2050.2790.7210.6930.790.7740.7450.7520.7480.587
Reseach & Development Expenses 47.93848.43439.22738.16742.19144.848101.09240.1450.6144.74245.89142.23222.36218.176000000000000000
General & Administrative Expenses 367.563400.584410.466456.984557.179566.165215.882118.649126.495137.216128.923121.518102.67198.596166.296150.789156.973200.07446.54274.567157.531136.6395.63931.18811.6128.93110.78338.41617.948
Selling & Marketing Expenses 1,390.0731,517.6471,531.6981,663.3691,893.3441,770.9141,248.026705.014638.702643.795572.308421.766399.653272.644237.861193.875149.365178.278226.921277.651323.416359.512309.93132.87824.73911.62515.38300
SG&A 1,757.6361,918.2321,942.1642,120.3542,450.5232,337.0791,463.908823.662765.197781.011701.231543.284502.324371.24404.157344.663306.338378.348673.463352.218480.946496.142405.56964.06636.35220.55626.16638.41617.948
Other Expenses 31.683813.383845.916659.763712.33476.487-87.0457.0217.8644.133260.65931.91234.14624.05334.89650.84160.22739.25-85.99218.7035.6513.02671.5340.8779.5163.5840.80.0030.542
Operating Expenses 2,667.7862,780.0482,827.3072,818.2833,205.0483,082.3791,991.4781,210.7771,140.1321,065.257937.977739.748653.705490.512412.932349.576311.101382.783678.38358.696485.349500.895410.8264.93837.10221.4426.9638.96418.23
Operating Income -1,468.03952.361,728.8081,916.1962,553.7611,027.8771,247.701647.741622.744153.52588.7578.33672.95383.663-37.819-25.86713.238-14.925-648.45923.799-212.19949.90165.88167.36426.29227.28617.62718.51110.931
Operating Income Ratio -0.040.0250.0420.0480.0620.0270.050.0480.0560.0160.0110.0120.0140.021-0.014-0.0120.005-0.006-0.2440.01-0.1660.060.0860.3390.2970.4230.2810.2380.219
Total Other Income Expenses Net -2,344.014-1,805.52-1,152.498-1,648.753-1,677.394-903.077-447.315-159.058141.122-208.6575.824-122.125-127.143-58.764-56.99422.32532.99937.471-307.744-88.546-81.867-34.583-24.102-24.1064.484.263-1.741-0.7120.478
Income Before Tax -1,458.474-853.16576.31267.443876.3671,055.3351,156.706653.82629.234156.714348.338108.18499.993107.717-3.61422.89773.46520.308-736.70635.529-208.29962.788116.26968.15335.80730.8718.42718.51311.472
Income Before Tax Ratio -0.04-0.0230.0140.0070.0210.0270.0460.0480.0570.0160.0440.0170.0190.027-0.0010.010.0290.008-0.2770.015-0.1630.0760.1520.3430.4050.4790.2940.2380.23
Income Tax Expense 260.559138.972318.443308.731361.466325.215332.914154.975110.74673.086119.0247.10338.10152.441-4.2266.05727.133.2961.9327.87710.14725.3343.1876.0014.524.4870.0950.7940.037
Net Income -1,689.945-992.131257.868-41.288514.902448.206639.191418.396474.73223.792117.04859.06752.52846.66914.15924.30438.6842.47-741.88622.07-219.95542.22779.81961.53431.06726.1518.15717.00511.372
Net Income Ratio -0.046-0.0260.006-0.0010.0120.0120.0260.0310.0430.0020.0150.0090.010.0120.0050.0110.0160.016-0.2790.01-0.1720.0510.1040.3090.3510.4060.290.2180.228
EPS -0.64-0.380.098-0.0160.190.170.240.190.650.0130.0660.0360.0320.0290.009-0.0080.020.019-0.480.011-0.140.0210.0340.0390.0220.0170.0120.0110.007
EPS Diluted -0.64-0.380.098-0.0160.190.170.240.190.650.0130.0660.0360.0320.0290.009-0.0080.020.019-0.480.011-0.140.0210.0340.0390.0220.0170.0120.0110.007
EBITDA 1,158.0421,228.5151,998.0472,110.4872,705.3172,443.8271,632.156940.429995.878450.031600.869331.927293.575266.095146.274162.912226.426168.757-600.471144.99-100.044142.86176.226129.83239.67729.44620.16819.22510.995
EBITDA Ratio 0.0320.0320.0490.0530.0650.0640.0650.0690.090.0460.0750.0520.0550.0670.0540.0740.0910.063-0.2260.062-0.0780.1720.230.6520.4490.4570.3220.2470.221